What conditions does Xenon Pharmaceuticals Inc. run trials for?

In our tracked recruiting trials, Xenon Pharmaceuticals Inc. sponsors trials for Depression, Epilepsy, Bipolar Depression.

Clinical trials sponsored by Xenon Pharmaceuticals Inc.

Recruiting trials

Conditions studied

Phase 3 4

Condition	Trials
Depression	2
Epilepsy	2
Bipolar Depression	1
Bipolar Disorder	1
Bipolar I Disorder	1
Bipolar II Disorder	1
Focal Onset Seizures	1
Major Depressive Disorder	1
Primary Generalized Tonic-Clonic Seizures	1

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
NCT07172516 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 44 locations
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
NCT06775379 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · 51 locations
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
NCT05716100 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 95 locations
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 138 locations